Ars Pharmaceuticals

Developer of therapeutics for the treatment of allergic reactions

placeSan Diego, California, United States calendar_todayFounded 2018 groups34 employees language ars-pharma.com

Registered entities

Investor mix

5 investors on record; lead investors include SR One, Deerfield.

Investor typeCountShare
Venture capital360%
Bank & private debt120%
Other / undisclosed120%
Coming soon